Global, regional, and national burden of chlamydial infection
A systematic analysis of incidence, prevalence, deaths, and Dalys with projections to 2046
Bibliographic Data
| ID | 22076229 |
|---|---|
| Authors | Jiawen Hu (0000-0003-3593-9985, First Affiliated Hospital of GuangXi Medical University), Jixu Hu, Yanni Lan (The People's Hospital of Guangxi Zhuang Autonomous Region), D Zhang (0000-0002-5027-5286, First Affiliated Hospital of GuangXi Medical University), Guipeng Lan (0000-0001-7321-7460, The Eighth People’s Hospital of Nanning, corresponding author), Jiyong Wei (0009-0002-6617-5105, First Affiliated Hospital of GuangXi Medical University, corresponding author) |
| Year | 2025 |
| Volume | 13 |
| Pages | 1674277-1674277 |
| Publication date | 2025-10-31 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Frontiers in Public Health (JOURNAL) |
| Journal identifiers | ISSN: 2296-2565 • E-ISSN: 2296-2565 |
| Publisher | Frontiers Media SA (PUBLISHER • CH) |
| DOI | 10.3389/fpubh.2025.1674277 |
| PMID | 41246104 |
| OpenAlex | W4415724308 |
| Language | EN |
| References cited | 44 |
Background: , imposes a substantial global health burden with uneven distribution. This study aims to quantify its global, regional, and national burden and project trends to 2046. Methods: Data from the Global Burden of Disease (GBD) 2021 study were analyzed. We estimated 2021 burden metrics, evaluated temporal trends from 1990 to 2021 using estimated annual percentage changes (EAPC), and projected trends for 2022-2046 using an age-period-cohort (APC) model. Results: In 2021, global incidence was 235.7 million [95% uncertainty intervals (UI): 172.9-334.7 million] with an age-standardized incidence rate (ASIR) of 2902.13/100,000; prevalence was 152.2 million [113.2-213.0 million; age-standardized prevalence rate (ASPR): 1874.56/100,000]. There were 1,033 deaths [683-1,370; age-standardized deaths rate (ASDR): 0.01/100,000] and 163,617 disability-adjusted life-years (DALYs) [116,493-227,160; age-standardized DALYs rate (ASDAR): 2.01/100,000]. Geographic disparities were striking: Southern Sub-Saharan Africa and Central Asia had the highest ASIR, while Western Europe and High-income North America had the lowest. Asia bore the largest absolute burden. Males showed higher incidence rates, while females experienced higher prevalence, deaths, and DALYs. Temporal trends (1990-2021) showed fluctuating case counts and declining age-standardized rates (ASRs), with regional variations. Projections to 2046 indicate divergent sex-specific trends, with rising female ASIR/ASPR but declining absolute cases among males. Conclusion: Chlamydial infection exhibits marked global disparities, necessitating targeted interventions including region-specific strategies and gender-responsive care to reduce its burden
Chlamydial infection · Health care · MEDLINE · Psychological intervention · Public health · Adolescent Sexual and Reproductive Health · Cervical Cancer and HPV Research · Reproductive tract infections research · Epidemiology
Global Estimates of the Prevalence and Incidence of Four Curable Sexually Transmitted Infections in 2012 Based on Systematic Review and Global Reporting
Chlamydia, gonorrhoea, trichomoniasis and syphilis
Urbanization and Health in Developing Countries
Epidemiological Synergy
Heterosexual risk of HIV-1 infection per sexual act
Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019
The impact of the Covid-19 pandemic on Sexually Transmitted Infections surveillance data
| Highly cited | No |
|---|